I wouldn’t mind seeing them partner for Long Haulers. That would allow for a larger trial with teams of staff to help determine dosing and everything needed to fully recognize how to attack that disease process. It’s a massive untouched market that Leronlimab could quite possibly own. That could totally fund all future cancer trials and just about anything else coming down the pipes. The main thing I want to see is credibility within the pharmaceutical world and the true potential of the drug recognized by the world.
I think it’s coming either way.
GLTUA